Public announcements from pharmaceutical companies or publications in major scientific journals

AI2BMD by Microsoft Research Transforming Biomedical Research and Drug Discovery

Nov 8, 2024, 02:00 PM

Recent advancements in artificial intelligence (AI) are revolutionizing the field of biomedical research and drug discovery. Microsoft Research has developed an AI model, AI2BMD, that can simulate proteins with more than 10,000 atoms with quantum accuracy, significantly faster than previous methods. Published in Nature, the results of AI2BMD align closely with wet-lab experiments, paving the way for new biomedical research breakthroughs. Additionally, companies like AbSci are leveraging AI to create drug candidates for previously unreachable targets, streamlining therapy development and reducing costs. SeanRMcClain and Andreas Busch of AbSci have highlighted these innovations. AI's capabilities are also challenging the role of quantum computing in complex simulations, with AI now able to simulate systems up to 100,000 atoms. These advancements highlight the transformative potential of AI in the fields of chemistry, materials science, and pharmaceuticals.